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ABSTRACT
The Afspl restriction-modification system, which
recognizes the sequence 5-CCGG-3', has been
previously cloned and sequenced (1). We subcloned
the methyltransferase gene (M.Afspl) downstream of
the ptac promoter In the multicopy vector pUC119 and
overexpressed it in E. coli. Upon induction with IPTG,
M.Afspl constitutes more than 10% of cellular protein.
A scheme has been devised to purify large amounts
of biologically active M.Afspl to apparent homogeneity
from these overexpressing E. coli cells. Approximately
0.8 mg of pure M.Afspl per gram of cells (wet weight)
can be obtained. The apparent molecular weight of
M.Mspl is 49 kD, by SDS gel electrophoresis and 48-54
kD by gel filtration. At low concentrations (less than
0.4 mg/ml), the methyltransferase is a monomer in
solution but at higher concentrations (greater than 3.0
mg/ml) it exists predominantly as a dimer. Polyclonal
antibodies raised against M.Afspl cross-react with the
DNA-methyltransferases of several other restriction-
modification systems.
INTRODUCTION
DNA methyltransferases are ubiquitous in living cells (2,3), but
in only a few cases have specific biological roles been defined.
In prokaryotes they often form part of restriction-modification
systems (4) or play an essential role in DNA mismatch repair
(5). In many plants, large amounts of 5-methylcytosine are present
(6), but its function is unknown. The dinucleotide CG is
frequently methylated in mammals and other higher eukaryotes
(7), and methylation of transcriptional control regions has been
correlated with the absence of transcription (8). Whether
methylation causes this inhibition of transcription or is the result
of transcriptional inactivity is undetermined. Many epigenetic
phenomena, such as imprinting (9), are postulated to involve the
effects of methylation but rigorous proof is still lacking.
Three kinds of DNA methylation are known, leading to
N6-methyladenine, N4-methylcytosine or 5-methylcytosine.
Much work has been done on the EcoRl methyltransferase, which
forms N6-methyladenine (10-12), and some studies have also
been carried out on other enzymes forming N6-methyladenine
(13). The Hhal (14) and £coRII methyltransferases (15,16), both
of which form 5-methylcytosine, have been studied extensively.
The reaction mechanism involves the formation of a covalent
intermediate between the 6-position of cytosine and a cysteine
residue that lies in a well-conserved region of all enzymes forming
5-methylcytosine (m5C-methylases) (17,18). Little is known
about the mechanism employed by enzymes forming
N4-methylcytosine.
We have been studying another m5C-methyltransferase,
M.Mspl, from Moraxella species (1). This enzyme recognizes
the sequence 5'-CCGG-3' and methylates the outer cytosine
residue (19). We are using this enzyme as a model system to
understand in detail how m5C-methyltransferases work both from
a mechanistic and a structural standpoint. We are especially
interested in defining the regions of the methyltransferase
responsible for sequence-specific DNA recognition and also to
define the mechanistic role of each of the motifs, previously
shown to be present in all sequenced m5C-methyltransferases
(20,21). In this paper we describe the preparation of a clone that
greatly overexpresses M.Mspl in E. coli and the subsequent
purification and preliminary characterization of this
methyltransferase.
MATERIALS AND METHODS
Chemicals and Reagents
Restriction and modification enzymes, except Clal and AjUB.
(from Bethesda Research Laboratories), DNA-ligase and
bacteriophage X-DNA were obtained from New England Biolabs
and used as recommended by the supplier. Reagents for
quantitative assay and SDS-polyacrylamide gel electrophoresis
were from BioRad and used as recommended. Nitrocellulose
membranes and the Western blotting kit (ProtoBlot, Rabbit) were
from Promega. Phosphocellulose PI 1 was from Whatman. The
FPLC columns Mono S and Mono Q were from Pharmacia.
Lysozyme, tetracycline, ampicillin, carbenicillin, protamine
sulfate and S-adenosyl-L-methionine (AdoMet) were obtained
from Sigma. [3H]-AdoMet (specific activity 11-13 Cj/mmole)
was from New England Nuclear. Scintillation fluid,
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Cytoscint™, was purchased from ICN Biomedicals, Inc. All
chemicals used were of the highest purity reagent grade.
Strains and Plasmids
E. coli K12, strain RR1 (22), was used as a host to overexpress
M.Mspl. Plasmid pNK627, which is a pACYC184 derivative
carrying the lacl^ gene inserted within its chloramphenicol
resistance gene, and plasmid ptacl2 (23,24) were obtained from
Dr. N. Kleckner (Harvard University). Plasmid pM921 which
carries the Mspl restriction-modification genes was described
previously (1). E. coli strain RR1, harboring the overexpressing
plasmid ps3 (see below) together with pNK627, was grown in
super broth (25), containing tetracycline (20 /tg/ml) and/or
carbenicillin (200 /ig/ml). Cultures were induced with 0.1 mM
IPTG at ODeoo approximately 1.2 and growth was continued for
3 hours.
Construction of the Mspl overexpression plasmid
Recombinant DNA experiments were performed using
established procedures (26). The steps involved in the
construction of the overexpression vector, ps3, are outlined in
Figure 1.
pBR322 was linearized with Ndel and resected to give blunt
ends using the Klenow fragment of E. coli DNA polymerase I.
The linearized plasmid was further treated with Hindm and a
2.1 kb Xfragment containing the ampicillin resistance gene and
the origin of replication was purified on a 1% agarose gel. A
3 kb EcoRl to HindHl fragment, containing the Mspl restriction-
modification genes, was isolated from pM921 such that the EcoRl
end had been rendered blunt by resection following the initial
cleavage. This 3 kb fragment was ligated to the 2.1 kb fragment
described above and was transformed into E. coli strain RR1.
Several individual transformants isolated on ampicillin plates were
tested for the presence of the gene for M.Mspl by assaying their
sensitivity to digestion with the Mspl restriction enzyme (R.MspT)
in vitro. The resulting 5.1 kb plasmid was designated pnl. DNA
from pnl was linearized with HindUl and partially digested with
Rsal and blunt-ended by treatment with the Klenow fragment of
DNA polymerase I. Fragments of approximately 3.5 kb were
gel-purified, ligated and transformed into E. coli. Individual
clones, isolated on ampicillin plates, were screened by restriction
enzyme digestion (Rsal, Ddel and TaqY) for the correct size and
for resistance to Mspl digestion in vitro. One isolate, designated
pq8, was used for further studies.
pq8 was cleaved with Clal and blunt-ended by treatment with
the Klenow fragment of DNA polymerase I. Following cleavage
with Pstl, the large Clal to Pstl fragment, containing the Mspl
methyltransferase gene was purified and ligated to the small Pstl
to PvwII fragment from ptacl2, containing the ptac promoter.
Following transformation into E. coli strain RR1 harboring
F'lacI0- individual colonies growing in ampicillin, were tested
for the presence of M.Mspl and analyzed by restriction enzyme
digestion. One clone, designated prl3, was cleaved with EcoRl
and Afim and the methyltransferase containing fragment was
recloned into pUC119, replacing the Smal to EcoRl fragment
from the polylinker. The resulting construct, showing ampicillin
resistance and M.Mspl activity, was designated ps3 and the key
elements of its structure confirmed by sequencing.
Purification of M.Mspl
M.Mspl was purified from E. coli strain RR1 carrying the
plasmid ps3 by the following procedure. All operations were
performed at 4°C unless stated otherwise.
Step 1: Preparation of crude extract and removal of nucleic
acids
Frozen cells (5 g, wet weight), from cultures grown and induced
at 37°C, were thawed at 4°C and suspended in 20 ml of buffer
A (10 mM potassium phosphate (pH 7.4), 1 mM Nc^EDTA, 14
mM /3-mercaptoethanol, 10% glycerol) containing 0.3 M NaCl.
The cell suspension was incubated with 15 mg lysozyme at 4°C
for 30 min and then sonicated. Following centrifugation at
31000xg for 30 minutes, 2.5 ml protamine sulfate (40 mg/ml)
was slowly added to precipitate nucleic acids and the supernatant
recovered by centrifugation.
Step 2: Chromatography on Phosphocellulose
Freshly prepared crude extract was diluted to a conductivity
equivalent to 0.15 M NaCl and applied to a phosphocellulose
column (22x53 mm) pre-equilibrated with buffer A containing
0.15 M NaCl. The column was operated at a flow rate of 1
ml/min. After sample loading, the column was washed with 80
ml of the starting buffer (buffer A + 0.15 M NaCl). Elution
was with 160 ml of a linear gradient from 0.15 M -1 .0 M NaCl.
Fractions (4ml) were assayed for M.Mspl activity and active
fractions were checked by SDS-polyacrylamide gel
electrophoresis before pooling. M.Mspl eluted between 0.3-0.4
M NaCl (Figure 3).
Step 3: FPLC chromatography on Mono S
The pooled fractions from the phosphocellulose column were
adjusted to 0.1 M NaCl, by dilution and loaded on a Mono S
column (HR 5/5) previously equilibrated with buffer A containing
0.1 M NaCl and running at a flow rate of 1 ml/min. The column
was washed for 10 minutes following loading and eluted with
40ml of a linear gradient from 0.1-0.5 M NaCl. Fractions (1
ml) were assayed for M.A/spI activity and peak fractions were
finally pooled based on their SDS-polyacrylamide gel profile.
The enzyme eluted from the column at a salt concentration slightly
above 0.2 M NaCl.
Step 4: FPLC Chromatography on Mono Q
The enzyme pool from the Mono S column was diluted to adjust
the conductivity equivalent to 0.1 M NaCl and applied to a Mono
Q column, previously equilibrated with buffer A containing 0.1
M NaCl. The column was washed for 10 minutes following
loading and eluted with 40 ml of a linear gradient from 0.1—0.4
M NaCl. Fractions were assayed as in Step 3 and the enzyme
eluted at a salt concentration slightly below 0.2 M. Pooled
fractions were dialyzed against storage buffer (0.1 M NaCl, 50
mM Tris-HCl pH 8.0, 10 mM Na2EDTA, 1 mM DTT, 50%
glycerol) and stored at -20°C.
Polyclonal antibodies against M.Mspl
Inclusion bodies were prepared from a 37°C induced culture (50
ml) of E. coli RR1, containing ps3 and F'lacR Cells were
suspended in 4 ml of lysis buffer (0.25 M NaCl, 20 mM Tris.HCl
pH8.0, 10 mM /3-mercaptoethanol, 1 mM Na2EDTA and 1
mg/ml lysozyme) and stored at 4°C for 30 min and then
sonicated. Following centrifugation, the pellet, which contained
the inclusion bodies, was washed with lysis buffer and
resuspended in 2 ml SDS sample buffer (5% glycerol, 30 mM
Tris.HCl pH 6.8, 0.1 % SDS, 0.35 M /3-mercaptoethanol, 0.02%
Bromophenol blue) and boiled for 5 minutes. The denatured
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inclusion bodies were separated on a 1.5 mm thick
polyacrylamide gel run under denaturing conditions (27). The
M.Mspl band was localized by Coomassie Blue staining in water,
excised and antigen samples were prepared and injected into
rabbits according to published procedures (28).
Western blotting, protein sequence analysis and dot-blot
analysis
SDS gel electrophoresis was carried out using standard
procedures (27). Proteins were electroblotted onto a
polyvinylidene difluoride (PVDF) membrane which was stained
with Coomassie Blue to locate the protein bands. For N-terminal
amino acid sequencing, the desired protein bands were excised
from the PVDF membrane and sequencing was performed on
an Applied Biosystems 475 protein sequencer. For immunoblot
experiments, proteins were separated on a 10% SDS
polyacrylamide gel and blotted onto a nitrocellulose membrane.
The blot was developed using the Alkaline Phosphatase System
from Promega following the procedure provided by the supplier.
Assay for methyltransferase activity
M.Mspl activity was measured qualitatively using a protection
assay in which bacteriophage X-DNA was incubated with die
methyltransferase and, following methylation, the DNA was
challenged with R.Mspl. A typical assay reaction was carried
out in 20 /tl reaction cocktail containing: 100 mM NaCl, 50 mM
Tris.HCl (pH8.0), 10 mM Na2EDTA, 14 mM /3-mercapto-
Figure 1. Construction of M.Mspl overexpression plasmid. The 3 kb EcoRl to
Hindm fragment, containing the Mspl restriction-modification genes, was obtained
from the original clone (1), subcloned into pBR322 and subsequently manipulated
as described in Methods. Restriction sites are abbreviated as follows: H: HindlU,
E: EcoRl, N: Ndel, R: Rsal, P: Pstl, Pv: Pvull, C: Clal, A: Aflm.
ethanol, 80 /xM S-adenosyl-L-methionine, 1 ng X-DNA and 2
(i\ of column fractions. The reaction mixture was incubated at
37CC for 30 min and then heated at 70°C for 5 min to inactivate
the methyltransferase. Following cooling, MgCl2 was added to
10 mM and incubated for 30 min at 37°C with R.Mspl (5 units).
The samples were analyzed by 0.8% agarose gel electrophoresis.
Quantitative measurements of M.Mspl activity were based on
the incorporation of tritiated methyl groups into substrate DNA.
The methylation reactions were carried out as above, except that
2.2 /tM [3H] S-adenosyl-L-methionine was included in the
reaction mixtures. Following incubation, samples were
withdrawn, adsorbed onto 2.5 mm Whatman DE81 paper circles
and immersed in 0.2 M (NH4) HCO3. Following washes with
0.2 M (NH,) HCO3, H2O and 100% ethanol the circles were
dried and counted.
The specific activity (units/mg protein) was based on the initial
rate of methyl transfer into substrate DNA. One unit of M.Mspl
incorporates 1 pmole of methyl group per min under standard
reaction conditions.
Molecular Weight Determination
The molecular weight of the reduced and denatured protein was
determined by 10% SDS-polyacrylamide gel electrophoresis
using appropriate molecular weight standards (BioRad). The
native molecular weight and state of aggregation of M.Mspl in
solution were determined by gel filtration chromatography on
Superose 12 (Pharmacia, HR 10/30, FPLC). The column was
equilibrated with 0.2M NaCl, 50mM Tris-HCl pH 8.0, 1 mM
Na2EDTA, 5% glycerol and then calibrated with standards of
known molecular weight; /3-amylase, alcohol dehydrogenase,
bovine serum albumin, carbonic anhydrase and cytochrome c.
The standard plot of molecular weight against partition coefficient
(29) was used to determine apparent molecular weights at
different protein concentrations.
!"-£»*>! Induction Temperoture37 °C 3O°C
.?..•
Figure 2. Inclusion body formation by M.Mspl. Panel A: E. coli cells were
harvested during logarithmic growth, fixed and examined by transmission electron
microscopy, (a) cells with no plasmid; (b) uninduced cells containing ps3; (c)
fully induced cells containing ps3; (d) a single cell containing an inclusion body
shown al high magnification. Panel B: Temperature sensitivity of inclusion body
formation. Cells were grown at 37°C until O D ^ =1 .2 , induced with 0.1 mM
IPTG and growth continued at either 30°C or 37°C. After 2 hours the cells were
harvested and analyzed by SDS polyacrylamide gel electrophoresis. Lane 1:
molecular weight markers, lane 2: total cellular protein from cells induced and
grown at 37°C cells, lane 3: insoluble protein from 37°C cells, lane 4: soluble
protein from 37°C cells. Lanes 5 - 7 correspond to lanes 2—4 except that cells
were induced and grown at 30°.
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RESULTS
Overproduction of M.Mspl in E. colt
From the original clone, pM921, containing the intact Mspl
restriction-modification system (1) the methyltransferase gene was
excised and placed downstream of the ptac promoter as indicated
in Figure 1. The final construct, ps3, contains approximately 130
nucleotides between the promoter sequence and the methionine
codon at which the translation of the methyltransferase gene
begins. When this plasmid is placed in E. coli RR1 containing
F'lacI^, expression from the ptac promoter is repressed and
little or no M.Mspl is detected by SDS gel electrophoresis of
total cellular protein. However, M.Mspl activity is present,
because in the absence of induction, this plasmid DNA is
completely resistant to the action of R.Mspl. Upon induction,
the strain produces high levels of the M.Mspl. However, the
methyltransferase protein becomes aggregated and is sequestered
in a biologically inactive form. Inclusion bodies can be seen inside
the cells when checked by electron microscopy (Figure 2, panel
A). These inclusion bodies are easily purified and contain large
quantities of the methyltransferase as judged by SDS-
polyacrylamide gel electrophoresis. Inclusion bodies have been
reported with several other overexpression systems (30-32).
It has been reported that the formation of inclusion bodies is
often dependent upon the growth temperature of the culture (33).
We have found that this is also the case for the M.Mspl inclusion
bodies. When the cells are grown at 37CC and induced at 37°C,
inclusion bodies are readily apparent, whereas if induction is
carried out at 30°C they are not produced (Figure 2, panel B).
From Figure 2B it can be seen that two prominent protein bands
are present in the insoluble fraction of the lysate, which contains
the inclusion bodies, and both bands disappear at the lower
temperature. The apparent molecular weight of the upper band
is 49 kD, in good agreement with the predicted molecular weight
of 47,659 calculated from the sequence (1). The lower band,
corresponding to an apparent molecular weight of 45 kD, could
represent a truncated version of M.Mspl. To test this possibility
we excised both bands from an SDS gel and subjected them to
N-terminal protein sequencing. The 49 kD band gave an
- 974 kDo
- 66 2 kDo
- - 2 1 5 kDo
— — 144 KDa
Figure 4. M.Mspl purification profile. Lane 1: crude extract after protamine
sulfate precipitation (30/ig). Lane 2: phosphocellulose pool (10/ig total protein).
Lane 3: Mono S pool (7/ig total protein). Lane 4: Mono Q pool (4/ig total protein)
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Figure 3. Phosphocellulose chromatography of M.AispI. The crude extract
recovered after protamine sulfate precipitation was chromatographed on
phosphocellulose and assayed as described in Methods. Panel A: SDS
poWacrylamidc gel analysis. Panel B: Protection assay. Panel C: Incorporation
of 3H-m«hyl groups and OD profile.
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Figure 5. Molecular size determination for M.Mspl. Panel A: Homogeneous
M.AfspI and the indicated marker proteins were subjected to 10% polyacrylamide
gel electrophoresis in the presence of 0.1 % SDS. The mobilities of the marker
proteins were used to calibrate the curve and the molecular weight of reduced,
denatured M.AfrpI was calculated by interpolation. Panel B: Native M.Mspl
(loading concentration 0.05 to 0.4 mg/ml) and various marker proteins were
subjected to gd filtration chromatography on Superose 12 as described in Methods.
The partition coefficients of the protein standards were used to calibrate the curve
and the molecular weight of native M.Mspl was calculated by interpolation. Panel
C: M.Mspl at various loading concentrations was subjected to Superose 12 gel
filtration chromatography and apparent molecular weights were calculated as for
Panel B.
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unambiguous sequence for 31 amino-acids. This sequence exactly
matched the N-terminal sequence predicted from the DNA
sequence, including the N-terminal methionine. The lower band
also contained an N-terminal methionine, but in this case the
sequence of 20 amino-acids, determined experimentally,
corresponded to a stretch of sequence beginning at the second
methionine in the M.Mspl open reading frame. This is located
40 amino acids downstream from the first methionine.
Purification
Protamine sulfate was used to clear the initial cell extracts of
nucleic acids and constituted the first step in the purification.
Subsequent fractionation of the M.Mspl preparation was achieved
by phosphocellulose (PC) chromatography (Figure 3) and resulted
in an approximately 14-fold increase in specific activity with a
recovery of more than 50% of the total activity. Further
chromatography by FPLC on Mono S resulted in a further
1.6-fold increase in specific activity with only a slight loss in
total activity recovered. The most prominent contaminant at this
stage appeared as a low molecular protein band (Figure 4, Lane
3). The last step in the purification was achieved by FPLC on
Mono Q which gave a 15% increase in specific activity with only
a modest loss of total activity recovered. The final pool from
this column appeared homogenous (Figure 4, Lane 4). As
summarized in Table 1, a routine purification procedure starting
with 5.0 g of fully induced cells yielded 4.0 mg of M.Mspl with
a specific activity of 7.4x10* units/mg. Figure 4 shows the
degree of purity attained at each purification step as visualized
by Coomassie blue staining of an SDS-polyacrylamide gel.
Molecular Weight and Homogeneity
The molecular weight of M.Mspl, under denaturing conditions,
was determined to be 49 kD by 10% SDS-polyacrylamide gel
electrophoresis (Figure 5, panel A). Attempts to determine the
molecular weight of native M.Mspl under non-denaturing
conditions by polyacrylamide gel electrophoresis were
unsuccessful, since we were unable to find conditions that would
enable the native protein to migrate into the gel. Other
experiments involving native gel systems such as isoelectric
focusing encountered similar difficulties because of the anomalous
behaviour of M.Mspl. These observations prompted us to
examine the possibility that M.Mspl might form aggregates in
solution. This was done by gel filtration chromatography.
M.Mspl, in the concentration range 0.05 to 3 mg/ml, was
chromatographed on an FPLC-Gel Filtration Column, Superose
12, calibrated with several protein standards (b-Amylase, Alcohol
Dehydrogenase, BSA, Carbonic Anhydrase and Cytochrome c
(Figure 5, panel B). At low concentrations, from 0.05 to 0.4
mg/ml, M.Mspl elutes predominantly as a monomer with an
apparent molecular weight of 48 to 54 kd. At higher
concentrations up to 3.0 mg/ml M.Mspl eluted with an apparent
molecular weight lying between the monomeric and dimeric
forms suggesting that dimerization was occurring, but that
dissociation to monomers took place during the elution. At
concentrations above 3.0 mg/ml, M.Mspl elutes predominantly
as a dimer with an apparent molecular weight of96kd (Figure 5,
panel C). Usually a shoulder was present in the void volume at
3 mg/ml that might represent an oligomeric form of M.Mspl (data
not shown). Quantitatively, the shoulder accounts for about 5%
Table 1. Purification Summary from 5g Cells
Purification
Step
Total
Protein (mg)
% Recovery
(Protein)
Specific activity
(Units/mg Protein)
Fold
Purification
14
22
25
Total
Activity
IO.8X1O3
8.8X1O3
6.0XI0 3
4.UX103
3.1X1O5
% Recovery
Activity
100
81
56
37
29
Crude
Protamine sulfate
Phosphocellulose
Mono S
Mono Q
365
300
15
6.1
4.2
100
82
4
1.7
1.2
2.96X103
2.92X1O3
4.0X104
6.4X104
7.4X104
9 1 9 9 * 9
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Figure 6. Immunological analysis of M.AfjpI. Panel A: Immunoblot analysis of M.AfspI in Monaxella sp. A crude extract of Moraxella species was analyzed by
Western analysis with polyclonal M.Mspl antibodies or preimmune serum. Lane 1: SDS gel-purified truncated form of M.Mspl (45kD). Lane 2: Moraxella extract.
Lane 3: SDS gel-purified intact M.Mspl (49kD). Panel B: Immunological cross reactivity of anti-M.AfjpI antibodies. Commercial preparations of methyltransferases,
as indicated, were fractionated by SDS gel electrophoresis and blotted onto a nitrocellulose membrane. The proteins were reacted with either pre-immune serum
(upper panel) or polyclonal M.Mspl antibodies (lower panel). Panel C: Dot blot analysis of native forms of M.Mspl and M.Hhal. Active methyltransferases were
adsorbed onto a nitrocellulose membrane and developed as for Panel A.
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of the total protein. Similar high molecular weight aggregates
were also observed by glycerol gradient centrifugation (data not
shown).
Antibodies to M.Mspl
To prepare polyclonal antibodies against M.Mspl we partially
purified inclusion bodies and subjected the resulting protein to
SDS gel electrophoresis. The 45 and 49 kD bands were excised
and used separately to inoculate rabbits. The resulting antisera
were tested for their ability to recognize authentic M.Mspl and
the results for the antiserum raised against the 49 kD protein are
shown in Figure 6, panel A. It can be seen that the antiserum
reacts with both the full length and the truncated methyltransferase
produced in E. coli. Similar results were obtained with the
antiserum raised against the 45 kD protein and so all further
experiments were conducted using the antiserum raised against
the 49 kD protein. To determine whether both forms are also
produced by the original strain, we examined a cell extract from
Moraxella sp. by Western blotting with the anti-M.MspI
antibodies. This experiment demonstrated that in Moraxella
species, only the higher molecular weight form is present
(Figure 6, panel A). This suggests that the formation of the
truncated protein is an artifact of the overexpression of the gene
in E. coli.
We also checked whether the M.Mspl antibodies showed cross-
reactivity with other m5C-methylases. For this experiment we
used commercial preparations of several methyltransferases,
which were extensively purified but were not homogeneous. As
shown in Figure 6, panel B, cross-reactivity was seen against
proteins of the correct molecular weight in commercial
preparations of the M.HpaU, M.Hhal, M.HaeUl and M.Alul,
all of which are known to be m5C-methylases (34). No reactivity
is detected against M.BamW, an N4C-methyltransferase (34) or
the adenine methyltransferases M.Clal and M.Pstl (34).
Surprisingly, the adenine methyltransferase M.fcoRI (34) does
show strong cross-reactivity. It should be noted that the pre-
immune serum also showed some cross-reactivity with M.£coRI,
although it was much enhanced in the immune serum (Figure 6,
panel B).
The distribution of epitopes responsible for antigenicity may
differ significantly for a reduced and denatured protein as
compared to a properly folded, active protein molecule.
Antibodies raised against denatured protein vary in their ability
to cross-react with native protein (28). Therefore we tested our
antibodies, raised against denatured protein, for their ability to
react with native M.Mspl and native M.Hhal. A strong signal
was observed against native M.Mspl. Interestingly, a weak, but
detectable signal was observed for native M.Hhal (Figure 6,
panel C).
DISCUSSION
We have constructed a clone that greatly overexpresses M.Mspl,
so that it accounts for at least 10% of total cellular protein. This
has been accomplished by using the strong hybrid promoter, ptac
(23,24), to drive transcription in a controllable fashion on the
high copy number plasmid ps3, a derivative of pUCl 19. Because
cells expressing M.Mspl induce the mcrB restriction system (35),
it was essential to use an mcrB~ strain and E. coli RR1 was
chosen. This strain also contained an F-factor, carrying lacl0,
to control the basal level of transcription from the ptac promoter.
However, it should be noted that even without induction M.Mspl
was produced at levels sufficient to render the ps3 DNA
completely resistant to the action of R.MspI.
Following induction, M.Mspl is greatly overproduced and
forms insoluble inclusion bodies. This is in contrast to other
methyltransferases, which have been overproduced in soluble
form, such as M.Hhal (36), M.HhaU (37), M.EcoRI (38) and
M.£coP15I (39). The M.Mspl inclusion bodies, as seen under
the electron microscope, are circular dense intracellular deposits
capable of distorting the cell shape. These inclusion bodies appear
morphologically distinct from those of eukaryotic proteins
overexpressed in E. coli (31). The M.Mspl aggregates are highly
insoluble and were fairly resistant to detergent treatment. Another
interesting anomaly was also observed during M.Mspl
overexpression. We routinely detected a lower molecular weight
band that had an N-terminal sequence beginning at the second
methionine in the M.Mspl coding sequence. We believe this
probably represents aberrant initiation at this codon, but cannot
rigorously exclude an N-terminal specific processing event.
One difficulty encountered during the purification of M.Mspl
was its propensity to aggregate. This property undoubtedly
facilitated the formation of inclusion bodies and hampered many
of our early attempts at purification. For instance, dialysis of
crude or partially purified enzyme preparations caused
aggregation and precipitation of M.Mspl. For this reason, we
devised a procedure that avoided dialysis. This had the bonus
of reducing purification time so that the final procedure could
be accomplished in 12 to 15 hours from cells to homogeneous
protein. Using the protocol described we were able to recover
as much as 4% of total cellular protein as soluble and active
methyltransferase. This estimate is based on the 25-fold
purification necessary to get pure enzyme and represents a lower
estimate of the total M.Mspl present in fully-induced cells. The
scheme described above has also been used successfully to purify
M.HpaU to homogeneity from a similar overexpression system
(Dubey, unpublished results) and may have general utility.
An interesting finding from this study is the immunological
cross-reactivity of the M.Mspl antibodies with m5C-methylases
from other restriction-modification systems. This may reflect the
fundamental structural similarities that have been found based
on sequence comparison (20,21). However, it should be noted
that antibodies raised against the human DNA methyltransferase
do not cross react with bacterial methyltransferases such as EcoRl
and Hpall (40). This is despite the fact that the C-terminal third
of the human enzyme is very similar to a complete bacterial m5C-
methylase. One possible reason for this difference could be that
the antibodies to the human enzyme were raised against native
protein (41), while ours were raised against denatured protein.
The extensive N-terminal region, unique to the human enzyme,
might be the principal antigen either by its nature or as a result
of folding to mask the C-terminal region. In contrast, our antibody
shows strong reactivity with native M.Mspl and even weak cross-
reactivity with native M.Hhal. These antibodies might prove
valuable in rapidly identifying bacterial strains that carry m5C-
methylases.
Most characterized DNA methyltransferases are functional as
monomers (42), although recently it has been reported that
M./tsrI shows partial dimerization in solution (43) and two
methyltransferases from Diplococcus pneumoniae appear to exist
as dimers (44). In both previous cases the effects could reflect
a tendency of the proteins to aggregate rather than having
functional significance. From our work it is clear that M.Mspl
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is functional as a monomer, but forms dimers and higher
aggregates as the enzyme concentration increases. This might
have been helpful for crystallization if the aggregation had
proceeded in an orderly manner, but so far it has proven
impossible to obtain crystals of M.Mspl either alone or complexed
with various DNA substrates (X. Cheng, unpublished
observations).
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